| LDR | 02598nam a2200373Ii 4500 | ||
| 001 | 102327129 | ||
| 003 | MiAaHDL | ||
| 005 | 20221205000000.0 | ||
| 006 | m d | ||
| 007 | cr bn ---auaua | ||
| 008 | 180215s1969 flua b f000 0 eng d | ||
| 035 | ⊔ | ⊔ | ‡a(MiU)990161191120106381 |
| 035 | ⊔ | ⊔ | ‡asdr-miu.990161191120106381 |
| 035 | ⊔ | ⊔ | ‡z(MiU)MIU01000000000000016119112-goog |
| 035 | ⊔ | ⊔ | ‡a(OCoLC)1023434670 |
| 035 | ⊔ | ⊔ | ‡z(MiU)Aleph016119112 |
| 040 | ⊔ | ⊔ | ‡aTRAAL ‡cTRAAL |
| 049 | ⊔ | ⊔ | ‡aMAIN |
| 086 | 0 | ⊔ | ‡aD 206.18:1095 |
| 100 | 1 | ⊔ | ‡aSimmons, William W., ‡eauthor. |
| 245 | 1 | 0 | ‡aIsoniazid prophylaxis as an aviation risk : ‡bpreliminary report / ‡cWilliam W. Simmons and Rosalie K. Ambler. |
| 264 | ⊔ | 1 | ‡aPensacola, Florida.: ‡bNaval Aerospace Medical Institute, Naval Aerospace Medical Center, ‡c1969. |
| 300 | ⊔ | ⊔ | ‡a7 pages : ‡billustrations ; ‡c28 cm. |
| 336 | ⊔ | ⊔ | ‡atext ‡btxt ‡2rdacontent |
| 337 | ⊔ | ⊔ | ‡aunmediated ‡bn ‡2rdamedia |
| 338 | ⊔ | ⊔ | ‡avolume ‡bnc ‡2rdacarrier |
| 490 | 0 | ⊔ | ‡aNAMI ; ‡v1095 |
| 500 | ⊔ | ⊔ | ‡a"Bureau of Medicine and Surgery, MF 12.524.005.5015B."--title page. |
| 500 | ⊔ | ⊔ | ‡a"25 November 1969." |
| 504 | ⊔ | ⊔ | ‡aIncludes bibliographical references (page 7) |
| 520 | ⊔ | ⊔ | ‡aThe question of the advisability of aviation personnel continuing in duties involving the actual control of aircraft while taking prophylactic isoniazid was studied. Specifically, adverse side effects of the drug were looked for both subjectively and objectively while subject personnel continued aviation duties. Fifteen aviation personnel were studied with clinical, laboratory, and psychometric examinations for a total of 862.5 person-months of drug ingestion. No significant adverse side effects which were thought to constitute a hazard to the safe performance of flying duties were detected. Although the expected incidence of adverse drug effects from isoniazid is small and no significant effects were detected for this small sample, it is suggested that a large number of subjects be studied prior to formulating a statement of policy in this regard. Meanwhile, aviation duties for personnel undergoing 300-mgm isoniazid therapy are judged to be allowable provided the flight surgeon maintains close scrutiny over such men. The long duration of the isoniazid therapy makes it economically desirable to continue personnel in a flight status. (Author). |
| 538 | ⊔ | ⊔ | ‡aMode of access: Internet. |
| 650 | ⊔ | 0 | ‡aFlight crews ‡xEffect of drugs on. |
| 650 | ⊔ | 0 | ‡aIsoniazid. |
| 700 | 1 | ⊔ | ‡aAmbler, Rosalie K., ‡eauthor. |
| 710 | 2 | ⊔ | ‡aNaval Aerospace Medical Institute (U.S.) |
| 710 | 1 | ⊔ | ‡aUnited States. ‡bNavy Department. ‡bBureau of Medicine and Surgery. |
| 730 | 0 | ⊔ | ‡aTechnical Report Archive & Image Library (TRAIL) |
| 899 | ⊔ | ⊔ | ‡a39015095162502 |
| CID | ⊔ | ⊔ | ‡a102327129 |
| DAT | 0 | ⊔ | ‡b20221205000000.0 |
| DAT | 1 | ⊔ | ‡a20221206061329.0 ‡b2024-04-27T17:34:56Z |
| CAT | ⊔ | ⊔ | ‡aSDR-MIU ‡cmiu ‡dALMA ‡lprepare.pl-004-008 |
| FMT | ⊔ | ⊔ | ‡aBK |
| HOL | ⊔ | ⊔ | ‡0sdr-miu.990161191120106381 ‡aMiU ‡bSDR ‡cGWLA ‡f016119112 ‡pmdp.39015095162502 ‡sMIU ‡1990161191120106381 |
| 974 | ⊔ | ⊔ | ‡bMIU ‡cGWLA ‡d20240427 ‡sgoogle ‡umdp.39015095162502 ‡y1969 ‡rpd ‡qbib ‡tUS fed doc |